Porvenir · Marketing for Pharmaceutical & Biotech Companies
Low Social Media Engagement
for
Pharmaceutical & Biotech Companies.
You're posting consistently. Almost nobody is engaging.
Fixed for pharmaceutical & biotech companies. Pharmaceutical and biotech companies must build scientific credibility and investor confidence simultaneously.
Signs pharmaceutical & biotech companies recognise
Does this sound
familiar?
Why this hits pharmaceutical & biotech companies hardest
Sector-specific
pressure points.
Brand not communicating scientific rigour and clinical credibility to investors and KOLs
No digital strategy for building awareness with HCPs before a product launch
Website failing to explain complex mechanism-of-action in terms stakeholders understand
No content strategy building authority in a competitive therapeutic area
Our approach
How we fix it
for pharmaceutical & biotech companies.
Audience & Platform Audit
We review where your actual audience is most active and engaged, which may not be the platform you're currently prioritising.
Content Strategy Reset
We define content pillars and formats proven to perform for your industry and audience, rather than posting without a plan.
Native-First Production
We produce content built for how each specific platform's algorithm and audience actually behave, not repurposed generic content.
Community & Iteration
We build in active engagement with your audience and iterate the content plan based on what's actually performing.
What pharmaceutical & biotech companies gain
Real outcomes.
Content built around what your specific audience actually engages with
A measurable lift in engagement rate and follower growth
A repeatable content strategy instead of reactive, one-off posting
FAQ
Common questions.
Do you specifically fix low social media engagement for pharmaceutical & biotech companies?
Yes. We understand the specific commercial context pharmaceutical & biotech companies operate in, and we apply that context directly to how we fix low social media engagement.
What causes low social media engagement for a pharmaceutical & biotech?
Content format or style that doesn't match platform-native behaviour These issues tend to compound for pharmaceutical & biotech companies because of brand not communicating scientific rigour and clinical credibility to investors and kols.
How quickly can you fix low social media engagement for our pharmaceutical & biotech?
Most engagements addressing low social media engagement for pharmaceutical & biotech companies show measurable movement within 30–60 days, with the full fix delivered over 4–10 weeks depending on scope.
What results should a pharmaceutical & biotech expect?
Content built around what your specific audience actually engages with A measurable lift in engagement rate and follower growth
Do you work with pharmaceutical & biotech companies outside our home market?
Yes - we work with pharmaceutical & biotech companies across North America, the UK, UAE, Europe, and Asia Pacific, delivered fully remotely.
Explore more
Related pages.
Other Problems We Solve for Pharmaceutical & Biotech Companies
- Poor Lead Quality for Pharmaceutical & Biotech Companies
- Poor Email Open and Click Rates for Pharmaceutical & Biotech Companies
- Competitors Outranking Us in Paid Ads for Pharmaceutical & Biotech Companies
- Can't Prove Marketing ROI for Pharmaceutical & Biotech Companies
- Social Media Gets Likes But No Sales for Pharmaceutical & Biotech Companies
Low Social Media Engagement for Pharmaceutical & Biotech Companies
Ready to fix
this for your pharmaceutical & biotech?
Book a discovery call. No pitch, no pressure - just a focused conversation about where you are and where you want to be.